One note is that Ratiopharm has capability for biogenerics via its daughter company - BioGeneriX, which has a filgrastim biosimilar (Ratiograstim) product on the market and several more in the pipeline.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.